Clinical Trial Update: A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SHR-A2102 versus investigator's choice of chemotherapy in patients with recurrent or metastatic cervical cancer after platin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• SHR-A2102

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Recurrent Cervical Cancer, Metastatic Cervical Cancer | Phase 3 | Status: RECRUITING